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ABSTRACT 
 
 Posterior reversible encephalopathy syndrome (PRES) is a radioclinical entity 
associating nonspecific neurological symptoms (headache, seizures, impairment of 
alertness, visual disturbances...) occurring in evocative clinical condition (hypertension, 
eclampsia, immunosuppressor agents, systemic lupus erythematosus...). In the acute 
stage, the typical imaging finding is a vasogenic edema predominant in the subcortical 
parietal-occipital white matter. 
 The purpose of this pictorial review is to illustrate the different neuroimaging 
features of PRES and present key radiological elements to assert diagnosis. In this 
overview, we examine the following points: the distributions of vasogenic edema, 
hemorrhage, the varying patterns in diffusion and perfusion, the different types of 
enhancement encountered and the vascular modifications demonstrated by 
angiography. The cause of PRES is still unknown. Nevertheless, catheter angiography, 
MR angiography and MR perfusion features in PRES render further insight into its 
pathophysiology. 
 Follow-up imaging shows evidence of radiologic improvement in the very large 
majority of cases in 1 or 2 weeks, sometimes in up to 1 month. Recurrent PRES attacks 
are uncommon. 
 Atypical imaging presentation should not reject the diagnosis of PRES in a 
compatible clinical situation. 
INTRODUCTION 
 
 PRES is a clinicoradiologic entity occurring in evocative clinical condition. Most 
cases of PRES occur in association with hypertension and/or immunosuppression. The 
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main cause of PRES is acute elevation of blood pressure above the upper limit of 
cerebral blood flow autoregulation.1 Besides hypertensive encephalopathy, PRES has 
been recognized in an increasing number of medical conditions, including 
preeclampsia and eclampsia2–5, vasculitis (Wegener's granulomatosis, systemic lupus 
erythematosus)6, acute or chronic renal diseases7,8, use of immunosuppressive drugs 
(Ciclosporine A, Tacrolimus, Vincristine, Cisplatin...)9–12, sepsis and shock13, blood 
transfusion14...  
 Clinical signs and symptoms include headache,   seizures, usually with 
electroencephalographic abnormalities most prominent over the posterior cortex, visual 
disturbances, including blurred vision, flashing lights or cortical blindness and 
hemiparesis.15,16  
 PRES may be suspected on the basis of history but the clinical findings are 
nonspecific so the diagnosis may be difficult to establish. Recognition of the 
characteristic imaging findings by radiologists is the key to diagnose this syndrome. MRI 
is the imaging mode of choice for the diagnosis and the follow-up in PRES. 
 Two theories have been promoted to explain the pathophysiology of vasogenic 
edema in PRES. In patients with hypertensive encephalopathy and in pregnant patients 
with eclampsia, PRES is thought to occur after a subacute elevation in blood pressure. 
Hypertension, when severe, may exceed the limit of autoregulation, leading to 
hyperperfusion and breakthrough vasogenic edema.17 Nevertheless, PRES developing 
and spontaneously reversing in normotensive patients suggests another mechanism 
than hypertension.13 Thus, the second hypothesized mechanism involves endothelial 
dysfunction secondary to systemic toxicity16 in immuno-suppressive therapy, eclampsia 
and sepsis. Intense cytokine response involving interleukin (IL-1, IL6) and tumour 
necrosis factor (TNF-a) in eclampsia18 and sepsis19 as well as immunosuppressors 20 
are known to cause endothelial cell injury 
DISTRIBUTION 
 
 The abnormalities affect primarily the subcortical white matter and often extend to 
the cortical surface sparing the deep white matter. Cortical, subcortical white matter and 
deep white matter edema are present in 18 to 29.0% of cases 21,22 (Fig. 1-3). 
 Focal or confluent vasogenic edema is present in the classic posterior parietal or 
occipital lobe region most consistently (≥ 98%)21,22 with additional involvement of the 
frontal lobes (≈ 70%), temporal region (≈ 65%) and cerebellum (30 to 53%)21–23 (Fig. 4). 
The distribution of lesions is mainly symmetrical (71%)24, but can be asymmetric  (Fig. 5) 
and even completely unilateral, simulating neoplasm.24 Bartynski WS. et al. describe 
three primary variations of the traditional PRES imaging pattern21:  
- Superior Frontal Sulcus Pattern with frontal abnormality linear and located along the 
superior frontal sulcus and no frontal pole extension, associated with varying degrees of 
parietal and occipital abnormality (Fig. 6A). 
- Holohemispheric Watershed Pattern spanning the frontal, parietal and occipital lobes 
with vasogenic edema present at the watershed (Fig. 6B). 
- Dominant Parietal-Occipital Pattern with involvement of the parietal and occipital white 
matter and cortex with variable involvement of the temporal lobes (Fig. 6C). 
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 The preferential distribution of white matter lesions in posterior brain regions is 
not well understood. Topographic variation in the cerebrovascular sympathetic 
innervation may be important25 and is generally accepted to result from the relatively 
sparse sympathetic innervation of the vertebrobasilar circulation26. The density of 
sympathetic innervation is maximal in the internal carotid and anterior cerebral 
territories.25,26 Sympathetic mediated vasoconstriction may be more effective in 
protecting the perforating small arterioles in the anterior circulation from overperfusion in 
acute hypertension.27 Because of this anterior to posterior gradient of sympathetic 
innervation, hyperperfusion state in perforating white matter arterioles and resulting 
edema might occur with a posterior to anterior gradient in patients with PRES.28 
 Less common areas of additional involvement include the thalamus (≈ 30%), 
basal ganglia (11,8 to 34%) and brainstem (12,5 to 27%)21–23 (Fig. 7). 
Isolated and extensive involvement of one or more of these structures without 
involvement of the parieto-occipital region is uncommon.  
Isolated involvement of the posterior fossa structures is rare. Posterior fossa lesions can 
lead to hydrocephalus and tonsillar herniation in the most severe cases. Some articles 
report brainstem and/or cerebellum extensively involved with supratentorial structures 
completely spared.29–31 This variant of PRES with predominant involvement of the 
posterior fossa remains unexplained. It has been reported that mild hypertension 
induces edema predominantly in the supratentorial white matter, whereas severe 
hypertension induces vasogenic edema in infratentorial structures, basal ganglia and 
thalamus32. Indeed animal studies have shown that mild acceleration of hypertension 
produced edema predominantly in the supratentorial white matter, while severe blood 
pressure elevations produced vasogenic edema infratentorially, as well as in the basal 
ganglia and thalamus. A greater involvement of the brainstem and deep structures at 
higher blood pressure maybe related to presence of small arteries that originate directly 
from larger trunks such as the middle cerebral artery and the basilar artery or its 
branches and thus subjected to high perfusion pressure levels. A severe elevation of 
blood pressure may be required for a blood-brain barrier breakdown in this location.32  
Several articles studied whether the distribution of the lesions differed in hypertensive or 
normotensive PRES, with contradictory results. 16, 23 
In Li et al. study including 28 patients, no significant difference existed in terms of the 
MRI distribution of vasogenic edema between PRES due to primary hypertension and 
PRES due to secondary causes.16 On the other hand, Fugate et al. demonstrated in a 
large clinical series (113 patients) that cerebellar involvement was significantly more 
frequent in patients with a history of autoimmunity compared with those without 
autoimmunity.23 
 Nine cases of spinal cord involvement are reported in the literature33–39. All 
patients had confluent expansile central spinal cord T2 hyperintensity spanning at least 
4 spinal segments, originating at the cervicomedullary junction. Only 5 of 9 patients had 
supratentorial involvement but all patients had brainstem involvement. All patients had 
severe acute hypertension. In one third of the cases clinical symptoms of spinal cord 
involvement were absent. De Havenon et al. propose a new syndrome named PRES 
with spinal cord involvement (PRES-SCI) that should be suspected when patients with 
PRES have neurologic signs referable to the spinal cord, extreme elevation in blood 
pressure, MRI lesions that extend to the cervicomedullary junction, or grade IV 
hypertensive retinopathy.39 
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HEMORRHAGE 
 
 Intracranial hemorrhage is known to occur in PRES in approximately 15-
64%.22,40,41 Three distinct types of hemorrhage could be identified: minute foci of 
hemorrhage (< 5mm) are more common than subarachnoid hemorrhage in cortical sulci 
or intraparenchymal hematomas41. Single or combined hemorrhage types could be 
present (Fig.1). Susceptibility-Weighted Imaging is more sensitive than conventional T2* 
gradient-recalled echo imaging in detecting cerebral hemorrhage and especially 
microhemorrhage.41 
 The mechanism of hemorrhage is presumed to arise from the phenomenon of 
breakthrough perfusion: rupture of pial vessels in the face of severe hypertension or 
vasoconstriction coupled with blood pressure instability predisposing to reperfusion 
injury42.  
 Hemorrhage type and frequency do not appear to be linked to blood pressure in 
patients with PRES. On the other hand, the rate of hemorrhage is greater in patients 
undergoing therapeutic anticoagulation and after allogeneic bone marrow 
transplantation compared with those with solid-organ transplantation.40 The incidence of 
microhemorrhage does not seem to correlate with the severity or extent of edema, the 
presence of DWI-positive findings or the presence of enhancement. Most 
microhemorrhage appear to persist on long-term follow-up.41 
DIFFUSION 
 
 Apparent diffusion coefficient (ADC) values in areas of abnormal T2 signal 
intensity are typically elevated consistent with highly mobile water in areas of vasogenic 
edema in PRES. These areas with increased ADC values may appear hyperintense, 
hypointense, or isointense on diffusion-weighted imaging (DWI), depending on the 
amount of the T2 “shine-through” effect.43–45 The majority of lesions appear hypointense 
or isointense on diffusion-weighted imaging (DWI).44 This phenomenon is called T2 
washout45: isointense lesions on DWI result from a perfect balance of T2 effects and 
increased water diffusibility whereas hypointense lesions on DWI have higher ADC 
values, which are not balanced by T2 effects (Fig. 11). 
 In some cases, ADC values can be paradoxically normal in areas of high DWI 
signal.44   These so called pseudonormalized ADC values may result from intravoxel 
averaging of both cytotoxic and vasogenic edema in the cortex affected by PRES. High 
DWI signal intensity and pseudonormalized ADC values seem to be correlated with 
cerebral infarction and may represent the earliest sign of nonreversibility as severe 
vasogenic edema progresses to cytotoxic edema44.  
 Focal areas of restricted diffusion are uncommon (11-26%).21,23 Coexistence of 
hypointense and hyperintense lesions on ADC mapping of the affected areas is  
frequently observed but purely cytotoxic edema  is also reported.24,46 
Many studies have shown that increased ADC values indicate vasogenic edema, most 
often reversible, while decreased ADC values indicate cytotoxic edema that inevitably 
induces cell death and progression to true infarction4,15,28,44,47. However, more recent 
studies produced contradictory results. In Kastrup et al. study of 50 patients with PRES, 
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two patients with purely cytotoxic edema did not show conversion to infarction.24 Several 
case reports illustrate reversibility of diffusion anomalies with restricted ADC in patients 
with PRES.46,48,49 Thus restricted diffusion does not always indicated  irreversible lesions 
(Fig. 2).  
 Seizures are a frequent manifestation of PRES and occipital lobe seizures are 
usually described as a common manifestation of this syndrome.50 Status epilepticus is 
reported in about 15% of patients with PRES51. It is often the main manifestation of 
PRES after pediatric allogeneic hematopoietic stem cell transplantation and could be a 
life-threatening event52. Status epilepticus in itself can lead to MRI changes53: 
hyperintensity on diffusion-weighted imaging with restricted diffusion involving the cortex 
and/or the ipsilateral pulvinar nuclei of the thalamus. Wakisaka et al.54 reported peri-ictal 
MRI findings in a patient with PRES that developed generalized tonic–clonic seizures. 
They demonstrated a gyriform cortical hyperintensity on DWI with decreased ADC 
around the sub-cortical occipitoparietal main PRES lesion with hyperintensity on DWI 
and increased ADC. These findings suggest that acute symptomatic partial epilepsy 
develops around the epileptogenic PRES lesion. 
PERFUSION 
 
 The cerebral vasculature is capable of maintaining a relatively constant flow of 
blood to the brain tissues over large fluctuations of systemic blood pressures. Two 
competing hypotheses have been suggested for the mechanism of brain edema 
formation in PRES.  
 The hyperperfusion theory remains widely accepted: severe hypertension with 
autoregulatory failure induces excessive blood flow and elevated capillary hydrostatic 
pressure, which causes fluid to leave the vessels and pass into the interstitial spaces. 
Investigating the brain effects of severe hypertension, a series of animal studies 
demonstrate that when the upper limits of autoregulation are exceeded, breakthrough 
occurs with the development of blood vessel alteration, capillary bed injury, vasogenic 
edema, and hyperperfusion.55,56 Case reports of patients studied with technetium 
Tc99m-hexamethylpropyleneamine oxime (Tc99m-HMPAO) single-photon emission CT 
(SPECT) or with Arterial Spin Labeling (ASL)57 showed increased perfusion in the 
vicinity of the brain that had abnormal signal.  
 The alternate hypothesis is that the hypertension induces compensator 
vasoconstriction, leading to decreased perfusion, brain ischemia and subsequent edema 
(Fig. 5, 12). Perfusion MR imaging is able to measure the cerebral blood volume (CBV), 
cerebral blood flow (CBF), mean transit time (MTT) and vascular permeability (K2). 
Bartynski W.S. et al. study found a rCBV markedly diminished (≤ 80% average) in 86 % 
of PRES lesions and regions compared with the healthy reference cortex. Brubaker L.M. 
et al. highlighted decreased posterior rCBF and rCBV, with heterogeneous patterns of 
MTT without changes in permeability by using the measure K2 and suggested that the 
interstitial edema seen in PRES might be caused by the elevation of capillary hydrostatic 
pressure mediated by venous constriction.58  
Hypoperfusion and hyperperfusion phenomenon could be intricately linked. Changes 
with time in the same patient with PRES are described, including initial vasoconstriction 
and hypoperfusion followed by rebound hyperperfusion.59 
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 rCBF color map can demonstrate increased perfusion in the occipital regions in a 
patient with PRES (Fig. 8, 9, 10). These perfusion abnormalities can be more extensive 
than FLAIR hyperintensities and are reversible (Fig. 8). In figure 9, increased perfusion 
preceded FLAIR hyperintensities in a symptomatic patient with recurrent PRES; to our 
knowledge, no other study has reported a comparable case. Hemodynamic changes can 
also be observed in peri-ictal states with focal cortical DWI hyperintensity and strong 
cortical hyperperfusion on ASL. In interictal state, hyperintense signals on DWI 
disappears and ASL demonstrates hypoperfusion or normal perfusion.60,61 In our case 
(Fig. 9), cortical hyperperfusion was symmetrical, contemporary with severe headache, 
preceded the seizure and can therefore be attributed to PRES. 
ENHANCEMENT 
 
 Intravenous contrast administration is not indicated to diagnose PRES but may be 
useful to exclude other clinical considerations. 
No enhancement or a slight cortical enhancement is typically observed. Contrast 
enhancement is reported in a variable incidence, ranking from 23 to 43%.22,24,62 
Leptomeningeal enhancement superficially above the brain surface is the most common 
pattern62 (Fig.13). Occasionally, a marked gyriform cortical enhancement can be 
observed.43 
 Leptomeningeal and cortical enhancement occur secondary to the breakdown of 
the blood-brain barrier.63 The pathophysiologic mechanisms of enhancement in PRES is 
related to endothelial injury or dysfunction. The direct toxic effects of tacrolimus and 
ciclosporin on cerebral endothelial cells have been demonstrated in animal models, 
these drugs induce apoptosis on the brain capillary endothelial cells.20 
As a rule, enhancement in PRES corresponds to the sites of parenchymal involvement. 
However, leptomeningeal enhancement occurring distant from the site of parenchymal 
involvement is possible.64 
 Compared to contrast-enhanced T1 weighted imaging, contrast enhanced fluid 
attenuated inversion recovery (CE-FLAIR) has been reported to have superior specificity 
and similar sensitivity in the detection of the inflammatory leptomeningeal lesions65.  It 
also seems to be true in PRES leptomeningeal lesions  (Fig. 7). Increased fluid-
attenuated inversion recovery signal intensity in the subarachnoid spaces on delayed 
enhanced MR imaging is also possible, believed due to cerebrospinal fluid gadolinium 
enhancement.66 
VASOSPASM 
 
 Vasculopathy is a common finding on catheter angiography or MR angiography in 
patients with PRES regardless of the cause. A multifocal cerebral vasoconstriction is 
noted in more than 85% of patients with PRES.5,13,67 Catheter angiography can 
demonstrate focal vasoconstriction, focal vasodilatation, string-of-bead appearance (Fig. 
13) most commonly observed in the second- and third-order branches and frequently 
associated with regions of vasogenic edema.13,68 Follow-up imaging demonstrates 
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reversal of vessel irregularities.5,13  
 These imaging features are close to those of the Reversible Cerebral 
Vasoconstriction Syndromes (RCVS). PRES and RCVS share many clinicoradiographic 
features, suggesting overlapping or similar pathophysiological mechanisms.69 Also, 
reversible brain edema occurs in 9–38% of all cases of RCVS.70,71 
FOLLOW-UP 
 
 Follow-up imaging shows evidence of radiologic improvement in the very large 
majority of cases with complete or near-complete resolution of abnormalities in about 
70% of cases23,24. Some patients reach complete resolution in 1 or 2 weeks and others 
experience widespread regression in up to 1 month (Fig. 5).24  
The syndrome is reversible if adequately treated72,73. High blood pressure treatment is 
important to avoid pronounced fluctuations of blood pressure. In patients with drug 
related and eclampsia related PRES, cessation of the immunosuppressant and delivery 
allows resolution of PRES.  
 Recurrent PRES attacks are rare (3,8-14%).74,75,16 Li R. et al.17 have 
demonstrated that patients with systemic hypertension as the primary etiology had a 
significantly higher rate of recurrence than patients with other causes of PRES 
(immunosuppression, chemotherapy, eclampsia....). They speculate that poor drug 
compliance in these patients has led to poor blood pressure control, predisposing them 
to higher risk of recurrence.16  
 Despite its name and classic reversibility, many patients still have permanent 
neurologic sequelae with a fatal out-come related to PRES in approximately 5-19%76,77. 
Risk factors for fatal outcome in PRES are not well identified. It seems that the influential 
factor to prognosis is the reversibility of lesions and hemorrhage.78,79 Hemorrhage on 
imaging portended the highest risk of fatal outcome. Not only frank intraparenchymal 
hematomas but also microhemorrhage appear to be correlated with a worse patient 
prognosis.77 
CONCLUSION 
 
 Vasogenic edema is most consistently present in the classic posterior parietal or 
occipital lobes. But despite the syndrome’s name, radiographic lesions in PRES are 
rarely isolated to the “posterior” parieto-occipital white matter and often involve the 
cortex, frontal lobes, temporal regions, cerebellum, thalamus and brainstem. 
 MRI is an efficient tool for early diagnosis and follow-up in PRES but atypical 
imaging findings must be known in order not to mistakenly reject the diagnosis of PRES: 
-hemorrhage is a common complication  
-DWI is essential but decrease in ADC values does not always correlate with 
nonreversibility of the lesions 
-intravenous contrast administration may demonstrate focal enhancement  
-perfusion MR imaging can demonstrate increased or decreased perfusion. Increased 
perfusion can precede the brain abnormalities on FLAIR images. 
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-multifocal cerebral vasoconstriction is commonly observed. 
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FIGURE CAPTIONS 
 
Figure 1. 7-year-old girl treated with ciclosporin for allogeneic bone marrow 
transplantation (Patient 1). 
Altered mental status and seizures. Brain CT scan (A) revealed a bilateral parietal-
occipital edema and a frontal subarachnoid hemorrhage (black arrow). FLAIR images 
(B-F) showed cortical and subcortical edema in temporal, parietal and occipital lobes 
with additional involvement along the superior frontal sulcus and the watershed zones of 
the frontal lobes and in temporal regions. T2* gradient-recalled echo imaging (G, H) 
detected microhemorrhage (white arrow) and subarachnoid hemorrhage (black arrow). 
 
Figure 2. Initial and follow-up imaging in the same patient (Patient1) at day 90. 
A. Subcortical white matter edema in temporo-occipital regions (white arrowhead) 
hyperintense on FLAIR and diffusion images with decreased ADC: reversibility of 
diffusion anomalies with complete recovery of the lesions at D90. 
B. Cortical and subcortical edema in right parietal region (white arrow). Cortical 
hyperintensities lesions on FLAIR, diffusion-weighted images and decreased ADC: 
irreversible cortical lesions on FLAIR images at D90. 
 
Figure 3. 69 year-old man with cerebellar syndrome and diplopia (Patient 2). Recurrent 
headaches for 4 days before hospitalization giving rise to suspicion of unstable 
hypertension. Symmetrical supra and infratentorial edema involving subcortical and 
deep white matter (F): corpus callosum (A), posterior limb of internal capsule (B), 
brainstem (C, D, E), middle cerebellar peduncles (D) and cerebellum (E, G). 
 
Figure 4.  Schematic representation of the various distributions of PRES lesions. 
Representation based on Bartynski et al.1, McKinney et al.22, Fugate et al.23 studies (a 
total of 332 cases of PRES).  
 
Figure 5. Asymmetrical presentation in a 66 year-old female with metastatic breast 
cancer treated by chemotherapy (Patient 3).  
Progressive restlessness and confusion without anomalies of the cerebrospinal fluid. 
Initial (A-F) and follow-up imaging at D30 (G) and D90 (H). 
Left parieto-occipital extensive edema with mass effect and contralateral subcortical 
superior frontal sulcus edema on T2 (A) and FLAIR (B) images. Pure vasogenic edema 
on diffusion-weighted images (C) and ADC map (D). Hypoperfusion within the parietal 
occipital edema on post-contrast  relative Cerebral Blood Volume (rCBV) map (E) with 
low rCBV (rCBV=0,4). No contrast-enhancement on T1-weighted post-contrast image 
(F). Complete but delayed radiological recovery at D90 (H). 
Figure 6. Schematic representation of the three primary variations of traditional PRES 
imaging pattern. 
6A. Superior Frontal Sulcus Pattern with frontal linear involvement located along the 
superior frontal sulcus. 
6B. Holohemispheric Watershed Pattern spanning the frontal, parietal, and occipital 
lobes with vasogenic edema present at the watershed. 
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6C. Dominant Parieto-Occipital Pattern with involvement of the parietal and occipital 
white matter and cortex with variable involvement of the temporal lobes. 
 
Figure 7. Basal ganglia and cortico-meningeal involvement in a thirty-four-year-old 
female with malignant hypertension and headaches 4 days after delivery (Patient 4). 
FLAIR sequences (A, D), T1-weighted image (E), post-contrast FLAIR (B) and T1-
weighted images (C, F).  
Cortical and subarachnoid hyperintensities on FLAIR (A) with leptomeningeal 
enhancement more remarkable on FLAIR post-gadolinium sequence (B) than on T1 post 
injection sequence (C). Bilateral symmetric hyperintensity of the striatum and focal 
hyperintensity in the splenium of corpus callosum on FLAIR (D) with striatal 
enhancement on T1-weighted post-contrast (F) images. 
 
Figure 8. 21-year-old female with systemic lupus erythematosus (Patient 5).   
Acute malignant hypertension, headaches and status epilepticus following treatment 
withdrawal. Favourable clinical evolution under anti-epileptic and anti-hypertensive 
drugs. Initial and follow-up imaging at D0, D10 and D40.  
D0: bilateral corticosubcortical FLAIR hyperintensities in the occipital lobes and anterior 
watershed regions with increased Cerebral Blood Flow (CBF) on CBF map generated by 
Arterial Spin Labeling perfusion (ASL). Follow-up MRI at D10 and D40: regression of the 
edema and progressive normalization of the CBF. 
 
Figure 9. Same patient (Patient 5) with PRES recurrence 6 months later.  
Initial MRI (D0): increased perfusion in occipital regions and anterior watershed regions 
on CBF color map (F) with slight focal cerebellar and occipital hyperintensities on FLAIR 
(A-C), without cortical signal abnormality on DWI (D-E). 
 
Figure 10. Patient 5, three days after figure 9 images (D3), neurological impairment and 
seizure.  
Extensive cerebellar vasogenic edema (A) complicated with hydrocephalus. Involvement 
of the parieto-occipital and frontal white matter (B-C) with increased diffusion (D) and 
ADC (E), increased perfusion in occipital regions and anterior watershed regions on 
CBF color map (F). 
 
Figure 11. Patient 5 at D3: T2 washout on diffusion images and cortico-meningeal 
involvement 
Cerebellar white matter edema (black arrowhead) on T2 (A), b0 (B), b1000 (C) diffusion-
weighted images (DWI) and ADC map (D): hypointense lesions on b1000 DWI with high 
ADC values.  
Subarachnoid hemorrhage (black arrow) in cerebellar sulci (E) on T2 Star Weighted 
ANgiography (SWAN). Leptomeningeal (white long arrow), intraparenchymal (white 
arrowhead) and cortical (white short arrow) enhancement on post-contrast T1-weighted 
images (F-H). 
 
Figure 12. Decreased perfusion in a 55-year-old female with history of psoriatic arthritis 
treated with Methotrexate, severe renal impairment and hypertension (Patient 6) 
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presenting with acute malignant hypertension, confusion, disorientation and right lateral 
homonymous hemianopsia.  
Vasogenic edema involving the parietal occipital white matter and the superior frontal 
sulcus on FLAIR sequences (A-D) with increased ADC (E) and decreased perfusion 
within parietal occipital edema on rCBV map from contrast-enhanced perfusion and 
FLAIR fusion imaging (F, G). 
 
Figure 13. Hemorrhages and vascular abnormalities in a 38-year-old female with altered 
mental status (Patient 7).  
Left frontal hematoma (white arrow) with intraventricular (black arrow) and subarachnoid 
hemorrhage on FLAIR (A-C) and T2* (D-E) images. Cerebellar and corticosubcortical 
parieto-occipital edema (A-C). Multifocal cerebral vasoconstriction in anterior and middle 
cerebral arteries branches with string-of-bead appearance on 3D TOF MR angiography 
(F) and catheter angiography (G, H) (arrowheads). 
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Highlights 
 
- MRI is an efficient tool for early diagnosis and follow-up in PRES 
 
- hemorrhage is a common complication  
 
- decrease in ADC values does not always correlate with nonreversibility of the lesions 
 
- perfusion MR imaging can demonstrate increased or decreased perfusion 
 
- multifocal cerebral vasoconstriction is commonly observed 
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